M. Dobrotová

发表

von Willebrand Factor, Soluble P-Selectin, Tissue Plasminogen Activator and Plasminogen Activator Inhibitor in Atherosclerosis

A. Blann, P. Kubisz, C. Mccollum, 1995, Thrombosis and Haemostasis.

Multimer Analysis of Von Willebrand Factor in Von Willebrand Disease with a Hydrasys Semi-Automatic Analyzer—Single-Center Experience

J. Hudeček, I. Škorňová, J. Staško, 2021, Diagnostics.

Monitoring of dabigatran therapy using Hemoclot® Thrombin Inhibitor assay in patients with atrial fibrillation

P. Galajda, F. Kovář, M. Mokáň, 2014, Journal of Thrombosis and Thrombolysis.

How can Secondary Thromboprophylaxis in High-Risk Pregnant Patients be Improved?

M. Grendár, J. Danko, T. Bolek, 2022, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Variability of GP6 gene in patients with sticky platelet syndrome and deep venous thrombosis and/or pulmonary embolism

P. Kubisz, M. Skerenova, M. Dobrotová, 2012, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Sticky platelet syndrome: an important cause of life-threatening thrombotic complications

J. Staško, P. Kubisz, P. Hollý, 2016, Expert review of hematology.

Yes or no for secondary prophylaxis in afibrinogenemia?

J. Staško, P. Kubisz, T. Simurda, 2015, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Diagnosis and management of von Willebrand disease in Slovakia

I. Škorňová, J. Staško, P. Kubisz, 2018 .

Successful Use of a Highly Purified Plasma von Willebrand Factor Concentrate Containing Little FVIII for the Long-Term Prophylaxis of Severe (Type 3) von Willebrand's Disease.

I. Škorňová, J. Staško, P. Kubisz, 2017, Seminars in Thrombosis and Hemostasis.

Long-term secondary prophylaxis with recombinant activated factor VII (rFVIIa) in haemophilia A with inhibitors: a case report.

J. Staško, P. Kubisz, P. Hollý, 2010, Thrombosis and haemostasis.

Genetic Background of von Willebrand Disease: History, Current State, and Future Perspectives

Z. Lasabová, I. Škorňová, J. Staško, 2019, Seminars in Thrombosis and Hemostasis.

The Importance and Complications of Sequencing of Von Willebrand Gene in Von Willebrand Disease

Z. Lasabová, I. Škorňová, J. Staško, 2019, Acta Medica Martiniana.

Perioperative Coagulation Management in a Patient with Congenital Afibrinogenemia during Revision Total Hip Arthroplasty

J. Staško, P. Kubisz, T. Simurda, 2016, Seminars in Thrombosis and Hemostasis.

A Novel Nonsense Mutation in FGB (c.1421G>A; p.Trp474Ter) in the Beta Chain of Fibrinogen Causing Hypofibrinogenemia with Bleeding Phenotype

M. Grendár, A. Casini, M. Neerman-Arbez, 2020, Biomedicines.

How Can Rotational Thromboelastometry as a Point-of-Care Method Be Useful for the Management of Secondary Thromboprophylaxis in High-Risk Pregnant Patients?

M. Grendár, J. Danko, T. Bolek, 2021, Diagnostics.

Monitoring of Hemostasis and Management of Anticoagulant Thromboprophylaxis in Pregnant Women with Increased Risk of Fetal Loss

J. Danko, I. Škorňová, J. Staško, 2016, Seminars in Thrombosis and Hemostasis.

DNA Polymorphisms in Pregnant Women with Sticky Platelet Syndrome

T. Burjanivová, M. Grendár, Andrea Hornáková, 2022, Journal of clinical medicine.

Anion-Active Surfactants Degradation by Immobilized Cells

P. Gemeiner, J. Huska, A. Vrbanová, 1996 .

Recombinant activated factor VII as an additional agent in the management of bleeding in patients with chemotherapy-induced thrombocytopenia.

P. Kubisz, P. Hollý, M. Dobrotová, 2013, Blood transfusion = Trasfusione del sangue.

Congenital afibrinogenemia: from etiopathogenesis to challenging clinical management

J. Staško, P. Kubisz, M. Dobrotová, 2016, Expert review of hematology.

Comparison of clinical phenotype with genetic and laboratory results in 31 patients with congenital dysfibrinogenemia in northern Slovakia

M. Grendár, Z. Lasabová, I. Škorňová, 2020, International Journal of Hematology.

Congenital Afibrinogenemia and Hypofibrinogenemia: Laboratory and Genetic Testing in Rare Bleeding Disorders with Life-Threatening Clinical Manifestations and Challenging Management

J. Hudeček, Z. Lasabová, R. Asselta, 2021, Diagnostics.

Heterogeneity of Genotype–Phenotype in Congenital Hypofibrinogenemia—A Review of Case Reports Associated with Bleeding and Thrombosis

J. Hudeček, M. Grendár, I. Škorňová, 2022, Journal of clinical medicine.

Severe Hemophilia and Physiologic Inhibitors of Coagulation

J. Staško, P. Kubisz, M. Dobrotová, 2005, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Perioperative Monitoring with Rotational Thromboelastometry in a Severe Hemophilia A Patient Undergoing Elective Ankle Surgery

I. Škorňová, J. Staško, P. Kubisz, 2023, Seminars in Thrombosis and Hemostasis.

Variability of GP6 gene in patients with sticky platelet syndrome and deep venous thrombosis and/or pulmonary embolism

P. Kubisz, M. Dobrotová, J. Ivankova, 2012, Blood Coagulation and Fibrinolysis.

Sticky platelet syndrome - current status and perspectives

J. Staško, P. Kubisz, P. Hollý, 2017 .

Sticky platelet syndrome in a patient with transitory ischemic attack and the family. A case report

L. Bartošová, P. Kubisz, M. Dobrotová, 2011 .